VGM & ASSOCIATESHealthcare MSO
Full Menu Search

The House of Representatives Passed the Lymphedema Treatment Act!

Published in Government Relations on November 17, 2022

Leg UpdateThis article was recently featured on LymphedemaTreatmentAct.org

Today, the full House of Representatives passed the Lymphedema Treatment Act, moving us one giant step closer to the bill becoming law! 

The vote was 402/13 - a tremendous show of bipartisan support! We will share a video as soon as it becomes available.

Now, we need to keep the momentum going - we have just one month to get the bill through the Senate! The last in-session day for this Congress is currently scheduled for December 16th. If the bill is not signed into law by the end of this Congress, then we have to begin the process all over again next January.

Please take a moment to thank House members and urge the Senate to follow suit and act swiftly to pass the LTA! Click here to send your email to the House and Senate in one step. And stay tuned for more action items in the new future.

We truly wouldn't be here without you. I know sometimes we all wonder if our voice makes a difference, but I can assure you it does. And you don't have to take my word for it. Just watch the video footage from the Committee Markup in July and the Floor Statements on Monday. Members of Congress repeatedly commented on how much hearing from advocates made a difference in bringing this issue to the forefront.

Your voice is making change happen!!

TAGS

  1. advocacy
  2. vgm government

Get Connected

Stay up-to-date on the latest resources and news provided by VGM & Associates.

Sign Up for Email

From Our Experts

Trump Administration Announces Nationwide DMEPOS Enrollment Moratorium thumbnail Trump Administration Announces Nationwide DMEPOS Enrollment Moratorium In a press release published on the CMS website Feb. 25, 2026, it was announced that CMS will implement a six-month moratorium on new enrollments for DMEPOS suppliers. VGM Response To CMS Moratorium On New DMEPOS Provider thumbnail VGM Response To CMS Moratorium On New DMEPOS Provider The federal moratorium on new DME suppliers presents a defining moment for us as an industry—an opportunity to demonstrate that the VGM members serving patients are the gold standard. We have long shown that our members operate with integrity, excellence in compliance, and unmatched commitment to service, efficiency, and patient outcomes. Now, we must elevate that message. Proposed LCD Changes to Impact Seat Elevation on Group 2 Non-Complex Power Wheelchair Bases thumbnail Proposed LCD Changes to Impact Seat Elevation on Group 2 Non-Complex Power Wheelchair Bases The DME Medicare Administrative Contractors (MACs) issued a proposed Local Coverage Determination (LCD) change for seat elevation use on group 2 non-complex power wheelchair bases (K0830, K0831 and K0108 on group 2 non-complex HD bases). John Quinlan Named 2026 Van G. Miller Homecare Champion thumbnail John Quinlan Named 2026 Van G. Miller Homecare Champion AAHomecare announced earlier this week that John Quinlan of Quinlan's Pharmacy in New York has been selected as the recipient of this year's Van G. Miller Award. John has been a valued VGM member for many years, and his leadership within the DMEPOS community has made a meaningful impact on patients, providers, and the industry as a whole. His commitment to quality care, patient access, and industry advocacy consistently sets him apart. Legislative Update On DMEPOS Bills – Letter To CMS Admin Dr. Oz To Delay Competitive Bidding Program thumbnail Legislative Update On DMEPOS Bills – Letter To CMS Admin Dr. Oz To Delay Competitive Bidding Program Many of you have already contacted your legislators in support of key DME legislation, including the DMEPOS Relief Act, the Choices for Increased Mobility Act, and the Supplemental Oxygen Access Reform (SOAR) Act. We now have another important issue to bring to your attention. CMS Revises Nebulizer Policy and ABN Form thumbnail CMS Revises Nebulizer Policy and ABN Form CMS has issued an update regarding revisions to the CMS Nebulizer Policy Article and guidance on the Advanced Beneficiary Notice of Noncoverage (ABN) Form. For dates of service on or after Feb. 1, 2026, suppliers must include the KX, GA, or GZ modifier to claims for the following nebulizer items: CMS Releases Updated Telehealth FAQ After Funding Bill Extends Flexibilities Through 2027 thumbnail CMS Releases Updated Telehealth FAQ After Funding Bill Extends Flexibilities Through 2027 Earlier this week, Congress extended Medicare telehealth flexibilities through Dec, 31, 2027, as part of the newly signed federal funding bill. In response, CMS has released updated Telehealth Frequently Asked Questions (FAQ) to provide clarity on what the extension means for both patients and providers. Shutdown Ends, Telehealth Prevails as Pres. Trump Signs Funding Bill thumbnail Shutdown Ends, Telehealth Prevails as Pres. Trump Signs Funding Bill The four-day partial federal government shutdown officially ended on Feb. 3, 2026, after President Donald Trump signed a $1.2 trillion funding package that reopens most federal agencies and restores key programs.

Give your business an advantage over the competition.

Become a Member